This presentation will highlight Clinical Outcomes, Valve Function, and Durability from the PARTNER 2 Aortic Valve-in-Valve Registries.

Valve-in-Valve (ViV) TAVR is a viable alternative for patients with failing surgical bioprosthetic valves

Although ViV TAVR was associated with acceptable mortality, improved valve hemodynamics, and excellent quality of life outcomes at 3 years, limited data are available on longer-term clinical outcomes, valve function, and durability.

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries

CRF TVT 2023

TVT Connect 2020 Series

Welcome to the TVT Connect 2020 Series, where you can find previous presentations and teaching sessions.

Anushka Mehrotra

Welcome to this module, in which we will cover the Clinical Trials are which are needed to Support MCS in the Modern Era

What Clinical Trials are Needed to Support MCS in the Modern Era?

This presentation will cover Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis

Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis

This presentation will highlight different techniques How to Use Intravascular Imaging to  Optimize CTO PCI

How to Use Intravascular Imaging to  Optimize CTO PCI

This presentation will discuss how to Assess and Treat INOCA  and MINOCA

How to Assess and Treat INOCA  and MINOCA

This presentation will highlight different approaches and challenges of Bifurcation PCI Techniques

Clinical Data Updates on Bifurcation PCI Techniques

This presentation will highlight different approaches and challenges of Annular Reduction Devices.

Annular Reduction Devices

In this presentation, Bernhard Meier, MD discusses the importance of PFO closure after ischaemic stroke.